ChemicalBook--->CAS DataBase List--->106400-18-4

106400-18-4

106400-18-4 Structure

106400-18-4 Structure
IdentificationBack Directory
[Name]

L-Glutamic acid, N-[4-[2-[(6S)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]- (9CI)
[CAS]

106400-18-4
[Synonyms]

DB04322
LY249543
LY243246
LY-249543
LY 249543
LY249543 sodium
LY249543 disodium
S-isomer of lometrexol
L-Glutamic acid, N-[4-[2-[(6S)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]- (9CI)
[Molecular Formula]

C21H25N5O6
[MDL Number]

MFCD34469239
[MOL File]

106400-18-4.mol
[Molecular Weight]

443.45
Chemical PropertiesBack Directory
[density ]

1.56±0.1 g/cm3(Predicted)
[pka]

3.60±0.10(Predicted)
Hazard InformationBack Directory
[Description]

LY249543, the S-isomer of lometrexol, is a Methylenetetrahydrofolate Dehydrogenase/Cycl inhibitor. Lometrexol is a folate analog antimetabolite with antineoplastic activity.
[Uses]

LY243246 ((6S)-DDATHF), the 6S diastereomer of DDATHF, is a potent competitive inhibitor of 5’-phosphoribosylglycinamide formyltransferase (GAR transformylase). 6R- and 6S-diastereomers of DDATHF are remarkably similar and equiactive antimetabolites inhibitory to de novo purine synthesis[1].
[References]

[1] Moran RG, et al. The 6S- and 6R-diastereomers of 5, 10-dideaza-5, 6, 7, 8-tetrahydrofolate are equiactive inhibitors of de novo purine synthesis. J Biol Chem. 1989;264(35):21047-21051. PMID:2592365
[2] Lehman NL. The stereospecific cytotoxic potency of (6R) and (6S)-5,10- dideazatetrahydrofolate correlates with cellular folylpolyglutamate synthetase levels. Biochimie. 1995;77(4):273-278. DOI:10.1016/0300-9084(96)88136-3
106400-18-4 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354 , +17819995354
Website: https://www.targetmol.com/
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:106400-18-4 Related Product Information